US Broker Ratings

Immatics N.V. (IMTX) Stock Analysis: Unveiling an 89.67% Potential Upside for Investors

For investors seeking exposure to the transformative potential of biotechnology, Immatics N.V. (NASDAQ: IMTX) presents itself as a compelling opportunity. Specializing in the healthcare sector, this Germany-based biopharmaceutical company is..

Savara, Inc. (SVRA) Stock Analysis: A Biotech Gem with 88.90% Potential Upside

Savara Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company, is currently making waves in the healthcare sector with its focus on rare respiratory diseases. Known for its lead product candidate, molgramostim,..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating Revenue Surge and Strategic Positioning

AMN Healthcare Services Inc (NYSE: AMN), a leader in providing technology-enabled healthcare workforce solutions and staffing services, stands as a pivotal player in the healthcare sector. With its current market..

Oculis Holding AG (OCS) Stock Analysis: Navigating a 190.92% Potential Upside in the Biotech Arena

As an individual investor looking for emerging opportunities in the biotech sector, Oculis Holding AG (OCS) presents a compelling case with its remarkable potential upside of 190.92%. This Swiss-based clinical-stage..

Immunome, Inc. (IMNM) Stock Analysis: Unpacking the 38.53% Potential Upside in Biotechnology

Immunome, Inc. (NASDAQ: IMNM) is making waves in the biotechnology sector with a current market capitalization of $2.92 billion. Despite its absence of traditional valuation metrics like a P/E ratio..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: A Biotech with a Potential 513% Upside

LENZ Therapeutics, Inc. (NASDAQ: LENZ) is making waves in the biotechnology sector with its innovative approach to treating vision disorders. As a commercial pharmaceutical company headquartered in Solana Beach, California,..

HealthStream, Inc. (HSTM) Stock Analysis: Exploring a 22.69% Potential Upside

HealthStream, Inc. (HSTM), a prominent player in the healthcare information services sector, is catching the attention of investors with its promising growth prospects and significant potential upside. Based in Nashville,..

Weave Communications, Inc. (WEAV) Stock Analysis: A 27.63% Upside in Healthcare Tech

As Weave Communications, Inc. (NASDAQ: WEAV) continues to carve out its niche in the healthcare technology sector, investors are keenly watching this innovative player. With a market capitalization of $529.91..

Intellia Therapeutics, Inc. (NTLA) Stock Analysis: Exploring Potential 127.65% Upside with CRISPR Innovations

Intellia Therapeutics, Inc. (NASDAQ: NTLA) is capturing the attention of investors with its pioneering advancements in CRISPR/Cas9-based technologies. As a clinical-stage genome editing company, Intellia is at the forefront of..

Ardelyx, Inc. (ARDX) Investor Outlook: Analyzing the 220% Potential Upside in Biotechnology

Ardelyx, Inc. (NASDAQ: ARDX) has captured investor attention with its potential for substantial upside in the biotechnology sector. With a market capitalization of $1.2 billion and a focus on developing..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: A 191% Upside Potential in the Biotech Arena

Gyre Therapeutics, Inc. (NASDAQ: GYRE) is garnering attention in the biotechnology sector with its focus on developing and commercializing groundbreaking small-molecule anti-inflammatory and anti-fibrotic drugs. With a market cap of..

Nutex Health Inc. (NUTX) Stock Analysis: A Strategic Play in Healthcare with a 62% Upside Potential

Nutex Health Inc. (NUTX), a key player in the healthcare sector specializing in medical care facilities, is catching the eye of investors with its substantial upside potential. With a market..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Exploring Its 34.13% Potential Upside in a Competitive Biotech Landscape

Arcus Biosciences, Inc. (NASDAQ: RCUS) is positioned in the dynamic biotechnology sector, a field known for its potential high-reward opportunities but also substantial risks. With a market capitalization of $3.61..

CareDx, Inc. (CDNA) Stock Analysis: Strong Revenue Growth and Investor Optimism Signal Potential Upside

CareDx, Inc. (NASDAQ: CDNA), a prominent player in the healthcare diagnostics and research industry, is catching the eyes of investors due to its robust revenue growth and encouraging analyst ratings...

Phibro Animal Health Corporation (PAHC) Stock Analysis: A Closer Look at a 26.76% Upside Potential

Phibro Animal Health Corporation (NASDAQ: PAHC), a prominent player in the healthcare sector under the specialty and generic drug manufacturing industry, presents an intriguing opportunity for investors seeking exposure to..

Evolent Health, Inc (EVH)

⚠️ No article content returned.

..

Harrow, Inc. (HROW) Stock Analysis: Exploring the 73% Upside Potential for This Eyecare Innovator

Investors with an eye for potential growth opportunities may want to take a closer look at Harrow, Inc. (NASDAQ: HROW), a dynamic player in the healthcare sector specializing in ophthalmic..

Azenta, Inc. (AZTA) Stock Analysis: Navigating Growth in the Life Sciences Sector

Azenta, Inc. (NASDAQ: AZTA), a notable player in the healthcare sector, operates within the medical instruments and supplies industry, offering a comprehensive portfolio of biological and chemical compound sample management..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Evaluating a 14.48% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG) stands at the intersection of healthcare and essential services, providing critical management and operational support to medical care facilities across the United States. With..

Integra LifeSciences Holdings C (IART) Investor Outlook: Target Price Hints at 9.37% Upside Potential

Integra LifeSciences Holdings Corporation (NASDAQ: IART) presents a compelling opportunity for investors eyeing the healthcare sector, specifically the dynamic field of medical devices. With a market capitalization of approximately $1.39..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds